Anterior Heel Wedge to Treat Flexion Contracture After Total Knee Arthroplasty
Efficacy of Anterior Heel Wedge at Reducing Knee Flexion Contracture After Total Knee Arthroplasty: A Pilot Investigation
1 other identifier
interventional
8
1 country
1
Brief Summary
Total knee arthroplasty (TKA) remains the only treatment for end-stage knee osteoarthritis, whereby the diseased ends of the bones comprising the knee joint are removed and replaced with prosthetic joint components. Approximately 500,000 of these procedures are performed annually in the United States. Despite an otherwise successful procedure and post-operative rehabilitation process, about 5% of all individuals will develop a flexion contracture after TKA. Flexion contracture limits the knee joint range of motion, which has negative impacts on activities of daily living and health-related quality of life. Standard of care treatment for resolving flexion contracture requires more surgery or, at minimum, more exposure to anesthesia to manipulate the joint and improve range of motion. The investigators have developed a non-invasive means for resolving flexion contracture, The investigators propose fixing a wedge to the sole of the patient's shoe such that the taller end of the wedge is located near the toes and the shorter end is closer to the heel. Biomechanically, this forces the individual to make ground contact during walking closer to the heel rather than the toes (which is typically observed in patients with flexion contracture). By forcing ground contact closer to the heel, patients gradually force their knee to extend (straighten) over time and resolve the flexion contracture. The aim of this pilot investigation is to test the hypothesis that the anterior wedge worn on the shoe during all walking activities for 4 weeks will reduce the severity of the flexion contracture in patients after TKA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Mar 2023
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2023
CompletedFirst Submitted
Initial submission to the registry
December 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedJune 2, 2026
May 1, 2026
2.8 years
December 19, 2024
May 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait biomechanics
Participants will walk over level ground at a self-selected pace and one equivalent to average older adult walking speed.
From enrollment to the end of treatment at 4 weeks
Secondary Outcomes (4)
Patient-reported outcomes
From baseline to the end of the intervention at 4 weeks
Patient-reported outcomes
From baseline to the end of the intervention at 4 weeks
Patient-reported outcomes
From baseline to the end of the intervention at 4 weeks
Patient-reported outcomes
From baseline to the end of the intervention at 4 weeks
Study Arms (1)
Orthotic
EXPERIMENTALParticipants enrolled in this arm wear an anterior heel wedge, in the form of a shoe orthotic, to improve walking and reduce knee flexion contracture. The wedge is worn continuously on the shoe for 1 month.
Interventions
A continuously-worn shoe anterior heel wedge that fits on the under surface of the shoe just under the toe box. When worn during walking, the anterior heel wedge may help to increase knee joint range of motion and reduce knee flexion contracture in patients after total knee arthroplasty.
Eligibility Criteria
You may qualify if:
- over the age of 18 years
- underwent primary, unilateral TKA and approved for participation by surgeon
- present with flexion contracture in the operative limb (5 degrees or greater at least 3 months after surgery)
- body mass index \<40kg/m\^2
You may not qualify if:
- underwent revision TKA
- underwent bilateral TKA
- require use of assistive device to walk
- inability to consistently comprehend and repeat back directions, including for reasons of not understanding/speaking English
- current smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC Charlotte
Charlotte, North Carolina, 28269, United States
Related Publications (1)
Sappey-Marinier E, Fernandez A, Shatrov J, Batailler C, Servien E, Huten D, Lustig S. Management of fixed flexion contracture in primary total knee arthroplasty: recent systematic review. SICOT J. 2024;10:11. doi: 10.1051/sicotj/2024007. Epub 2024 Mar 26.
PMID: 38530205RESULT
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 19, 2024
First Posted
June 2, 2026
Study Start
March 16, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
June 2, 2026
Record last verified: 2026-05